Currently Viewing:
The Academy of Managed Care Pharmacy (AMCP) 2018
Dr Calvin Knowlton on Innovative Practices in Enhanced Medication Therapy Management
May 20, 2018
Dr Tina Joseph Outlines Pharmacists' Role in Managing Chronic Diseases, Value-Based Care Models
May 19, 2018
Brian Litten Outlines Challenges With Adopting Medication Therapy Management Services
May 17, 2018
Currently Reading
Dr Kimberly Lenz: Identifying Patients Most at Risk For Substance Abuse
May 13, 2018
The Rise of Orphan Drugs for Rare Diseases
May 07, 2018
Dr Calvin Knowlton Outlines Benefits Seen From Enhanced Medication Therapy Management
May 06, 2018
Dr Aimee Tharaldson on Recently Approved Specialty Drugs, Upcoming Approvals to Watch
May 05, 2018
Hemophilia: Treatment Landscape, Costs, and Disease Management
April 26, 2018
Navigating the Rocky Waters to Value-Based Healthcare
April 26, 2018
Dr Tina Joseph Discusses Collaborative Practice Agreements Between Pharmacists, Physicians
April 26, 2018
Dr Somali Burgess on the Role of Patient-Reported Outcomes in Managed Care Pharmacy
April 26, 2018
Cardiologist Talks About Value of Monoclonal Antibody Evolocumab
April 26, 2018
Market Access Teams Face New Challenges in Pharma
April 25, 2018
Migraines in the US Are More Than Just a Pain Problem
April 25, 2018
Dr Aimee Tharaldson Discusses Key Market Trends in Specialty Pharmacy
April 25, 2018
Dr Brandon Newman Discusses Payer, Academic Medical Center Collaboration
April 25, 2018
Who Decides What Value Looks Like in US Healthcare?
April 24, 2018
Brian Litten Outlines How Medication Therapy Management Can Address Opioid Misuse
April 24, 2018
Dr Robert Navarro Discusses Progress in Shift to Value-Based Care
April 24, 2018

Dr Kimberly Lenz: Identifying Patients Most at Risk For Substance Abuse

Kimberly Lenz, PharmD, clinical pharmacy manager, MassHealth/Office of Clinical Affairs, University of Massachusetts Medical School, discusses identifying patients most at risk for misusing or abusing controlled substances and how approaches to treatment differ for these patients.


Kimberly Lenz, PharmD, clinical pharmacy manager, MassHealth/Office of Clinical Affairs, University of Massachusetts Medical School, discusses identifying patients most at risk for misusing or abusing controlled substances and how approaches to treatment differ for these patients.

Transcript

How can you identify patients at greatest risk for misuse or abuse of controlled substances?

It’s a really tricky question. I think a lot of health plans use risk stratification tools to help them identify members at the greatest risk. At our plan, we currently use the methodology of 11 or more controlled substances written by 4 or more providers or filled by 4 or more pharmacies. We are looking to change that into a more risk-based criteria, where it’s not an arbitrary number of prescriptions or providers, more a combination of things that put a member at greater risk of either an overdose or some other concerning event. So, we’re looking at combinations of opioids and benzodiazepines, gabapentins, stimulants, skeletal muscle relaxants, and then combining that potentially with not just the number of opioids they’re receiving, but their milligrams of morphine equivalence, which has been shown in the literature to correlate to overdose events.

Is the approach to treatment different for these patients?

I think it has to be. So, you can’t just assume the criteria will be a one-size-fits-all for everybody. So, I think you have to take into consideration if you have a beneficiary who recently started on addiction treatment or had a significant change in their medical history—recent diagnoses of cancer, things like that. I think you have to give those members a little bit more time before you put them into a program to see what their long-term treatment will look like.

 
Copyright AJMC 2006-2018 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up
×

Sign In

Not a member? Sign up now!